Phase IV Trial to Determine the Safety and Immunogenicity of the WHO Formulation of the 2006-2007 Fluzone® Vaccine

NCT00389532 · clinicaltrials.gov ↗

PHASE4

Phase

COMPLETED

Status

116

Enrollment

INDUSTRY

Sponsor class

Conditions

Influenza

Interventions

BIOLOGICAL: Influenza Virus Vaccine (2006-2007 Fluzone® vaccine)
BIOLOGICAL: Influenza Virus Vaccine (2006-2007 Fluzone® vaccine)

Sponsor

Sanofi Pasteur, a Sanofi Company